Reconsidering the Value of Baseline PET/CT in Early-Stage Breast Cancer: Evidence for Selective Use from the MF21-02 Multicenter Study
Background: The role of ^18F-FDG PET/CT in the initial staging of early-stage breast cancer remains controversial, as current guidelines discourage its routine use due to the low prevalence of distant metastases. This study aimed to evaluate the diagnostic yield and clinical impact of baseline PET/CT in a large multice...